Læknaneminn - 01.04.1997, Síða 114

Peter Duesberg and David Rasnick
6.2. Nine out of ten American/European AIDS
patients are males. The drug hypothesis predicts that
American and European AIDS is predominantly male,
because males consume over 78% of the hard injected
drugs (Table 4) 53,61, over 98% of nitrite inhalants 79,80
and most of the AZT (see 3., 4. and 7.).
Indeed, the CDC reports that 87% of all American
AIDS patients are males 227. And the sex ratio of the
European AIDS epidemic is a mirror image of the
American drug epidemic 26. This sex distribution is
the sum of the following constituents:
1) The CDC reports that a third of all American
AIDS patients are intravenous drug users 3. According
to the NIDA, the US Department of HHS and the
Bureau of Justice Statistics, and the White House 75-
78% ofdrug users are males 26-52'53'sl’«5 (see 3. andTable 4).
2) The CDC also reports that nearly two thirds, over
60%, of all American AIDS patients are male homo-
sexuals 228. Based on self-answered questionnaires 229
(of the CDC and independent investigators) all of
these were frequent users of nitrite inhalants, eth-
ylchloride inhalants, amphetamines, cocaine, and other
drugs that facilitate sexual contacts, particularly anal
intercourse. Indeed, not a single drug-free homosexu-
al AIDS case has ever been documented in the litera-
ture (see 3. and Table 5).
Since intravenous drug users, who are 75% male,
make up one-third of all AIDS patients, and male
homosexuals make up almost two-thirds of all
American AIDS patients, the drug hypothesis explains
why 87% of all American AIDS patients are males.
The same applies to the European AIDS epidemic.
6.3. AIDS anddeaths from recreationaldrugs have the
same age distribution. The drug hypothesis predicts
that the age distributions of deaths from AIDS and
from recreational drugs coincide.
Indeed, this prediction is already proved. In 1994,
89% of all American AIDS cases 3, and 82% of all
American drug deaths fell into the age group between
25 and 54 years 61. In 1990, 82% of the cocaine-relat-
ed and 75% of the morphine-related hospital emer-
gencies were 20-39 years old, again overlapping very
closely with the age distribution of AIDS patients 230.
Moreover, according to the same sources, 77% of the
drug deaths and 82% of the AIDS cases in 1994 were
males - a remarkable coincidence (Table 4).
6.4. Pediatric AIDS caused by maternal drug addic-
tion. The drug hypothesis predicts AIDS in babies
who shared intravenous drugs and AZT with their
mothers - regardless of HIV.
In fact, over 80% of pediatric AIDS cases in America
and Europe are babies born to mothers who were intra-
venous drug users 2S'205’231-233. Since 1989, many were
also prescribed AZT and other anti-HIV drugs after
birth (see 4. and 6.9.). The remainder reflects the nor-
mal low incidence of AIDS-defming diseases among
newborns, particularly among newborns of poor and
homeless mothers.
6.5. Why AIDS now? The drug hypothesis predicts
that American and European AIDS is new because it is
a direct consequence of the drug use epidemics that
spiraled after the Vietnam war, from negligible num-
bers in the 1970s to currently about 20 million illict
drug users in America (see 3.). Allow a grace period of
about 10 years for recreational drugs to achieve the
dosage needed to cause irreversible disease 26 and you
can date the origin of AIDS in 1981 (see 3. and 6.7.).
In addition, the drug hypothesis predicts that addi-
tional AIDS cases were generated since 1987 by the
epidemic of AZT prescriptions for 220,000 HIV-posi-
tives 26 (see 4.).
According to the CDC’s HIV/AIDS Surveillance
Reports, AIDS in America increased from a few dozen
cases annually in 1981 to about 50,000-75,000 since
1990 224 (Fig. 1). The peak in 1992 and 1993 reflects
in part yet another increase in the list of AIDS-defin-
ing diseases; this time to about 30 17 (Fig. 1). After
1993 the annual incidence of AIDS cases has leveled
off and even appears to decline (Fig 1). A comparison
of Figures 1 and 2 graphically underscores the parallels
between the AIDS and drug epidemics since 1981.
Thus American and European AIDS is new because
the drug epidemic is new. In fact, both the newness
and the growth of the AIDS epidemic are predicted by
the newness and the growth of the drug epidemic, as
postulated by the drug-AIDS hypothesis.
6.6. Risk group-specific AIDS diseases. The drug
hypothesis predicts drug-specific AIDS diseases and
explains the following risk-group-specific AIDS dis-
eases as drug-specific AIDS diseases:
1) Kaposi’s sarcoma specific for male homosexual nitrite
LÆKNANEMINN
112 1. tbl. 1997, 50. árg.